Accessibility Menu
 
Charles River Laboratories International logo

Charles River Laboratories International

(NYSE) CRL

Current Price$159.14
Market Cap$7.84B
Since IPO (2000)+623%
5 Year-45%
1 Year+1%
1 Month-5%

Charles River Laboratories International Financials at a Glance

Market Cap

$7.84B

Revenue (TTM)

$4.02B

Net Income (TTM)

$144.34M

EPS (TTM)

$-2.96

P/E Ratio

-53.84

Dividend

$0.00

Beta (Volatility)

1.28 (Average)

Price

$159.14

Volume

20,349

Open

$163.09

Previous Close

$159.14

Daily Range

$153.26 - $163.15

52-Week Range

$91.86 - $228.88

CRL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Charles River Laboratories International

Industry

Life Sciences Tools and Services

Employees

19,700

CEO

James C. Foster

Headquarters

Wilmington, MA 01887, US

CRL Financials

Key Financial Metrics (TTM)

Gross Margin

33%

Operating Margin

11%

Net Income Margin

-4%

Return on Equity

-4%

Return on Capital

7%

Return on Assets

-2%

Earnings Yield

-1.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.84B

Shares Outstanding

49.23M

Volume

20.35K

Short Interest

0.00%

Avg. Volume

953.07K

Financials (TTM)

Gross Profit

$1.23B

Operating Income

$507.84M

EBITDA

$911.15M

Operating Cash Flow

$737.65M

Capital Expenditure

$219.15M

Free Cash Flow

$518.49M

Cash & ST Invst.

$213.77M

Total Debt

$3.07B

Charles River Laboratories International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$994.23M

-0.8%

Gross Profit

$307.86M

+8.3%

Gross Margin

30.96%

N/A

Market Cap

$7.84B

N/A

Market Cap/Employee

$418.99K

N/A

Employees

18,700

N/A

Net Income

$276.56M

-28.2%

EBITDA

$198.50M

+329.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.85B

-12.7%

Accounts Receivable

$708.86M

-1.7%

Inventory

$299.10M

+7.4%

Long Term Debt

$3.00B

+10.3%

Short Term Debt

$61.06M

N/A

Return on Assets

-2.02%

N/A

Return on Invested Capital

7.13%

N/A

Free Cash Flow

$58.57M

-30.1%

Operating Cash Flow

$147.52M

-7.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
QGENQiagen N.V.
$39.07-1.61%
BAXBaxter International Inc.
$15.97-4.20%
BIOBio-Rad Laboratories, Inc.
$265.40-4.02%
RVTYRevvity, Inc.
$83.90-3.70%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$167.52-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%

Questions About CRL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.